The estimated Net Worth of David Botstein is at least $367 millier dollars as of 12 February 2021. David Botstein owns over 160,000 units of Pacific Biosciences of California Inc stock worth over $268,800 and over the last 12 years he sold PACB stock worth over $0. In addition, he makes $98,333 as Independent Director at Pacific Biosciences of California Inc.
David has made over 1 trades of the Pacific Biosciences of California Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 160,000 units of PACB stock worth $707,200 on 12 February 2021.
The largest trade he's ever made was exercising 160,000 units of Pacific Biosciences of California Inc stock on 12 February 2021 worth over $707,200. On average, David trades about 13,333 units every 0 days since 2012. As of 12 February 2021 he still owns at least 160,000 units of Pacific Biosciences of California Inc stock.
You can see the complete history of David Botstein stock trades at the bottom of the page.
Dr. David Botstein Ph.D. serves as Independent Director of the Company. Since January 2014, Dr. Botstein has been the Chief Scientific Officer at Calico Life Sciences, L.L.C. Dr. Botstein was formerly Director of the Lewis-Sigler Institute for Integrative Genomics and Anthony B. Evnin Professor of Genomics at Princeton University, where he served from 2003 to 2013. From 1990 to 2003 he was Chairman of the Department of Genetics at Stanford University. Previously, he was Vice President for Science at Genentech, Inc. He is a member of the National Academy of Sciences and the Institute of Medicine and has received numerous awards for his achievements in science. Dr. Botstein has made fundamental contributions to modern genetics, including the discovery of many yeast and bacterial genes and the establishment of key techniques that are commonly used today. In 1980, Dr. Botstein and three colleagues proposed a method for mapping genes that laid the groundwork for the Human Genome Project. Dr. Botstein holds a Ph.D. in Human Genetics from the University of Michigan and an A.B. in Biochemical Sciences from Harvard. Botstein possesses specific attributes that qualify him to serve as a member of our Board of Directors, including his extensive experience in the life sciences industry.
As the Independent Director of Pacific Biosciences of California Inc, the total compensation of David Botstein at Pacific Biosciences of California Inc is $98,333. There are 11 executives at Pacific Biosciences of California Inc getting paid more, with Michael Hunkapiller having the highest compensation of $859,188.
David Botstein is 77, he's been the Independent Director of Pacific Biosciences of California Inc since 2012. There are 1 older and 17 younger executives at Pacific Biosciences of California Inc. The oldest executive at Pacific Biosciences of California Inc is Lucy Shapiro, 79, who is the Independent Director.
David's mailing address filed with the SEC is PACIFIC BIOSCIENCES OF CALIFORNIA, INC., 1305 O'BRIEN DRIVE, MENLO PARK, CA, 94025.
Over the last 14 years, insiders at Pacific Biosciences of California Inc have traded over $95,441,111 worth of Pacific Biosciences of California Inc stock and bought 2,252,330 units worth $6,097,136 . The most active insiders traders include Michael Hunkapiller, John F Milligan et Christian O Henry. On average, Pacific Biosciences of California Inc executives and independent directors trade stock every 44 days with the average trade being worth of $202,112. The most recent stock trade was executed by Jeff Eidel on 19 August 2024, trading 26,760 units of PACB stock currently worth $42,548.
pacbio develops comprehensive solutions for scientists that propel the field of genomics, improve science and research, and create positive impact globally. we provide sophisticated genomic analysis systems that deliver invaluable insights for scientists who strive to resolve complex genetic challenges. our strength comes from the dedication of our people, who are fueled by a desire to effect real, positive change. with a focus on the future and an experienced, passionate team, we are motivated to continue to redefine what is possible in genomics.
Pacific Biosciences of California Inc executives and other stock owners filed with the SEC include: